Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis

We compared the performance and levofloxacin (Quinsair) lung deposition of three nebulisers commonly used in CF (I-Neb Advance, eFlow rapid, and LC Plus) with the approved nebuliser Zirela. The delivered dose, delivery rate, and aerosol particle size distribution (APSD) for each device were determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Carsten, Procaccianti, Claudio, Costa, Laura, Brini, Riccardo, Friend, Richard, Caivano, Grazia, Sadafi, Hosein, Mussche, Charles, Schwenck, Nicolas, Hahn, Michael, Murgia, Xabier, Bianco, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455972/
https://www.ncbi.nlm.nih.gov/pubmed/36076992
http://dx.doi.org/10.3390/ijms23179597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455972/
https://www.ncbi.nlm.nih.gov/pubmed/36076992
http://dx.doi.org/10.3390/ijms23179597

Ejemplares similares